Cardiology

AHA: Inclisiran twice yearly may effectively control cholesterol

(HealthDay)—A new injectable medication called inclisiran cuts low-density lipoprotein (LDL) cholesterol by half or more, and the effect could last for four to six months, according to research presented at the annual meeting ...

Cardiology

PCSK9 inhibitors reduce lipoprotein (a) production

A new study published today in JACC: Basic to Translational Science sheds light on PCSK9 inhibitors, a new class of low density lipoprotein (LDL) lowering drugs, and their impact on another risk factor for heart disease, ...

Cardiology

Cholesterol test for one-year-olds? Study says it could help

What if a blood test could reveal that your child is at high risk for early heart disease years in the future, giving you a chance to prevent it now? A big study in England did that—screening thousands of babies for inherited ...

Cardiology

Severe obesity and heart failure

(HealthDay)—Severe obesity appears to be an independent risk factor for heart failure, a new study suggests.

page 38 from 40